Phenylethylidenehydrazine (PEH) is an inhibitor of the enzyme GABA transaminase (GABA-T). It is a metabolite of the antidepressant phenelzine and is responsible for its elevation of GABA concentrations. PEH likely plays a significant role in phenelzine’s high efficacy in treating anxiety disorders.
This page contains content from the copyrighted Wikipedia article "Phenylethylidenehydrazine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
